Doliver Advisors’s Celgene Corp CELG Stock Holding History

Doliver Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,403	Closed	-$344K	–	176
2019 Q3	$344K	Sell	3,403 -404	-11%	-$38.4K	0.14%	69
2019 Q2	$352K	Buy	3,807 +34	+0.9%	+$3.23K	0.14%	59
2019 Q1	$356K	Buy	3,773 +332	+10%	+$29K	0.14%	54
2018 Q4	$221K	Buy	3,441 +8	+0.2%	+$591	0.11%	112
2018 Q3	$307K	Sell	3,433 -15	-0.4%	-$1.33K	0.13%	100
2018 Q2	$274K	Buy	3,448 +45	+1%	+$3.74K	0.11%	137
2018 Q1	$304K	Buy	+3,403	New	+$327K	0.13%	142

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Doliver Advisors's CELG Position: Q4 2019 in Review

Doliver Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,403 shares — an estimated $344K sold.

Doliver Advisors first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $356K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Doliver Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Doliver Advisors sold 3,403 Celgene Corp shares in Q4 2019, an estimated $344K.
Doliver Advisors first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
Doliver Advisors's Celgene Corp position peaked at $356K in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Doliver Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.